博士伦(BLCO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BLCO 博士伦

交易中 09-30 10:01:48 EDT

16.98

-0.16

-0.93%

最高17.18	最低16.90	成交量3.91万
今开17.18	昨收17.14	日振幅1.58%
总市值60.51亿	流通市值7.73亿	总股本3.56亿
成交额66.32万	换手率0.09%	流通股本4,550万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BLCO","market":"US","secType":"STK","nameCN":"博士伦","latestPrice":16.98,"timestamp":1790776898077,"preClose":17.14,"halted":0,"volume":39059,"delay":0,"changeRate":-0.009334889148191373,"floatShares":45501700,"shares":356382628,"eps":-0.481351,"marketStatus":"交易中","change":-0.16,"latestTime":"09-30 10:01:48 EDT","open":17.175,"high":17.175,"low":16.904,"amount":663198.189305,"amplitude":0.015811,"askPrice":16.99,"askSize":52,"bidPrice":16.94,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.481351,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1790798400000},"marketStatusCode":2,"adr":0,"listingDate":1651809600000,"exchange":"NYSE","adjPreClose":17.14,"postHourTrading":{"tag":"盘后","latestPrice":17.14,"preClose":17.14,"latestTime":"19:30 EDT","volume":8219,"amount":140874.52,"timestamp":1790724605887,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.855023,"impliedVol":0.247,"impliedVolPercentile":0.0558},"requestUrl":"/m/hq/s/BLCO","defaultTab":"news","newsList":[{"id":"1189011712","title":"美FDA于9月4日向博士伦发出警告信","url":"https://stock-news.laohu8.com/highlight/detail?id=1189011712","media":"投资观察","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1189011712?lang=zh_cn&edition=full","pubTime":"2026-09-15 22:49","pubTimestamp":1789483776,"startTime":"0","endTime":"0","summary":"路透社9月15日消息——美国食品药品监督管理局 官网披露，该机构已于9月4日向博士伦公司发出警告信。据悉，此次警告信直指博士伦位于坦帕市的药品生产设施，指出其存在严重违反现行药品生产管理规范的行为。FDA的检查发现，该生产基地在质量管控和生产流程方面存在重大缺陷，这些问题可能对药品安全性及有效性构成潜在风险。值得注意的是，这并非FDA首次对制药企业发出此类警告。截至目前，博士伦尚未就此事发表公开回应。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","BLCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667640783","title":"美国食品药品监督管理局：向博士伦发出警告信，原因是其坦帕制药工厂存在严重的现行生产质量管理规范违规行为。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667640783","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667640783?lang=zh_cn&edition=full","pubTime":"2026-09-15 21:41","pubTimestamp":1789479665,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4198","BLCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666343525","title":"博士伦：SEELYRA滴眼液未来几个月将率先在欧洲上市，2027年实现更广范围推广。","url":"https://stock-news.laohu8.com/highlight/detail?id=2666343525","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666343525?lang=zh_cn&edition=full","pubTime":"2026-09-11 18:12","pubTimestamp":1789121524,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IPOS","BK4198","BLCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666552534","title":"博士伦的 Seelyra 激光设备获得欧盟 CE 认证。","url":"https://stock-news.laohu8.com/highlight/detail?id=2666552534","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666552534?lang=zh_cn&edition=full","pubTime":"2026-09-11 18:11","pubTimestamp":1789121504,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4198","BLCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666953603","title":"Leerink Partners首次覆盖博士伦，给予“跑赢大市”评级及24美元目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=2666953603","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666953603?lang=zh_cn&edition=full","pubTime":"2026-09-09 22:12","pubTimestamp":1788963127,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BLCO","BK4198","UUP","UDN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125360841","title":"博士伦基于试验结果推进两款首创眼科疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=1125360841","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1125360841?lang=zh_cn&edition=full","pubTime":"2026-08-25 05:06","pubTimestamp":1787605571,"startTime":"0","endTime":"0","summary":"8月24日（路透社）——博士伦公司今日宣布，基于积极的临床试验数据，公司将推进两款首创眼科治疗药物的研发进程。与此同时，博士伦的BL1332在1b期临床试验中达到了主要终点，显示出显著的疼痛缓解效果。公司预计，BL1332眼科疼痛疗法的二期临床试验结果将在未来几个月内公布。博士伦指出，这两款治疗药物的潜在年销售额合计有望超过20亿美元。公司对这两款创新疗法的市场前景充满信心，认为它们将满足眼科领域未尽的医疗需求。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLCO","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105956290","title":"博士伦二季度调整后每股收益0.15美元，与市场预期一致","url":"https://stock-news.laohu8.com/highlight/detail?id=1105956290","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1105956290?lang=zh_cn&edition=full","pubTime":"2026-07-29 19:10","pubTimestamp":1785323431,"startTime":"0","endTime":"0","summary":"博士伦（Bausch + Lomb Corp.）公布了第二季度财报，调整后每股收益为0.15美元，与IBES预测的0.15美元持平。这表明公司在当季的盈利表现完全符合市场预期。\n此外，博士伦第二季度运营收入达到8300万美元。这一数字反映出公司在核心业务运营上的稳健态势，为投资者提供了清晰的业绩参照。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLCO","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113434276","title":"博士伦Q1调整后每股收益0.05美元 低于IBES预估0.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1113434276","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1113434276?lang=zh_cn&edition=full","pubTime":"2026-04-29 19:13","pubTimestamp":1777461225,"startTime":"0","endTime":"0","summary":"4月29日 - 博士伦第一季度营收达12.44亿美元，超越IBES此前12.18亿美元的预期值。尽管营收表现亮眼，公司当季调整后每股收益为0.05美元，略低于市场普遍预期的0.06美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLCO","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123136637","title":"财报前瞻｜博士伦本季度营收预计增5.82%，机构多持正面判断","url":"https://stock-news.laohu8.com/highlight/detail?id=1123136637","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1123136637?lang=zh_cn&edition=full","pubTime":"2026-04-23 00:58","pubTimestamp":1776877132,"startTime":"0","endTime":"0","summary":"博士伦将于2026年04月29日发布财报，市场聚焦收入韧性与盈利修复节奏。上一季度博士伦营收为14.05亿美元，同比增长9.77%，毛利率为62.06%，归属于母公司股东的净利润为-5,800.00万美元，净利率为-4.13%，调整后每股收益为0.32美元，同比增长28.00%。基于近半年的公开观点信息，机构侧以看多为主导，占比高于看空阵营。本季度一致预期显示营收同比增长5.82%，EBIT同比增长9.07%，调整后每股收益同比增长115.06%，多项指标反映利润弹性正在逐步释放。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜博士伦本季度营收预计增5.82%，机构多持正面判断","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113635853","title":"Bausch & Lomb第四季度调整后每股收益为$0.25，超出预期的$0.24，销售额为$12.8亿，超出预期的$12.6亿","url":"https://stock-news.laohu8.com/highlight/detail?id=1113635853","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1113635853?lang=zh_cn&edition=full","pubTime":"2025-02-19 20:07","pubTimestamp":1739966866,"startTime":"0","endTime":"0","summary":"Bausch & Lomb  报告季度调整后每股收益为$0.25，超过分析师预期的$0.24，增幅为4.17%。这比去年同期的销售额$11.7亿增长了9.12%。以上内容来自Benzinga Earnings专栏，原文如下：Bausch & Lomb  reported quarterly adjusted earnings of $0.25 per share which beat the analyst consensus estimate of $0.24 by 4.17 percent. This is a 4.17 percent increase over earnings of $0.24 per share from the same period last year. The company reported quarterly sales of $1.28 billion which beat the analyst consensus estimate of $1.26 billion by 1.69 percent. This is a 9.12 percent","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Bausch & Lomb第四季度调整后每股收益为$0.25，超出预期的$0.24，销售额为$12.8亿，超出预期的$12.6亿","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509272367","title":"Bausch + Lomb Corporation盘中异动 股价大跌7.97%报16.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509272367","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509272367?lang=zh_cn&edition=full","pubTime":"2025-02-06 22:32","pubTimestamp":1738852365,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日22时32分，Bausch + Lomb Corporation股票出现异动，股价急速跳水7.97%。截至发稿，该股报16.34美元/股，成交量22.9289万股，换手率0.07%，振幅1.75%。Bausch + Lomb Corporation股票所在的医疗设备行业中，整体跌幅为0.19%。Bausch + Lomb Corporation公司简介：Bausch & Lomb 总部位于加拿大魁北克省拉瓦尔市，是美国销售额第四大的视力保健公司，也是印度和中国消费者视力保健的市场领导者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223246abc4d4d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223246abc4d4d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4198","BLCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507630892","title":"加拿大皇家银行：维持Bausch & Lomb(BLCO.US)评级，由优于大市调整至优于大市评级, 目标价由23.00美元调整至22.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2507630892","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507630892?lang=zh_cn&edition=full","pubTime":"2025-01-29 23:45","pubTimestamp":1738165530,"startTime":"0","endTime":"0","summary":"加拿大皇家银行：维持Bausch & Lomb(BLCO.US)评级，由优于大市调整至优于大市评级, 目标价由23.00美元调整至22.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/29234547898765.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BLCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507633723","title":"Stifel：维持Bausch & Lomb(BLCO.US)评级，由持有调整至持有评级, 目标价由19.00美元调整至18.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2507633723","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507633723?lang=zh_cn&edition=full","pubTime":"2025-01-29 21:22","pubTimestamp":1738156968,"startTime":"0","endTime":"0","summary":"Stifel：维持Bausch & Lomb(BLCO.US)评级，由持有调整至持有评级, 目标价由19.00美元调整至18.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/29212247898165.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BLCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503346301","title":"博士伦(BLCO.US)先进enVista Aspire人工晶体在欧盟上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2503346301","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503346301?lang=zh_cn&edition=full","pubTime":"2025-01-13 21:10","pubTimestamp":1736773848,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，博士伦(BLCO.US)周一宣布，在去年年底获得CE认证后，enVista Aspire 单焦点和复曲面人工晶体(IOLs) 在欧盟上市。enVista Aspire将新型中间优化光学器件与enVista平台的成熟优势相结合，以满足现代数字世界的视觉需求。博士伦外科总裁Luc Bonnefoy表示：“世界各地的外科医生早就知道enVista平台的优势。”截至发稿，博士伦盘前涨2.42%，报18.19美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1237044.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4198","BLCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2490386337","title":"Bausch + Lomb Corporation盘中异动 早盘大幅下挫11.67%报18.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490386337","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2490386337?lang=zh_cn&edition=full","pubTime":"2024-12-11 22:32","pubTimestamp":1733927551,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日22时32分，Bausch + Lomb Corporation股票出现异动，股价大幅下跌11.67%。截至发稿，该股报18.24美元/股，成交量45.5515万股，换手率0.13%，振幅1.65%。Bausch + Lomb Corporation股票所在的医疗设备行业中，整体涨幅为0.22%。Bausch + Lomb Corporation公司简介：Bausch & Lomb 总部位于加拿大魁北克省拉瓦尔市，是美国销售额第四大的视力保健公司，也是印度和中国消费者视力保健的市场领导者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211223231a1e66b4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211223231a1e66b4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4198","BLCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2490074264","title":"黑石集团或退出竞购博士伦 交易规模达130亿至140亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490074264","media":"观点网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2490074264?lang=zh_cn&edition=full","pubTime":"2024-12-11 09:14","pubTimestamp":1733879640,"startTime":"0","endTime":"0","summary":"观点网讯：12月11日，据知情人士透露，黑石集团可能退出与TPG的联合竞购，涉及全球知名的眼保健公司博士伦。此次竞购案涉及金额高达130亿美元至140亿美元，若交易成功，将成为2024年私募股权市场上最大规模的收购之一。博士伦作为一家拥有171年历史的眼科巨头，在全球范围内拥有超过12000名员工，业务覆盖约100个国家及地区，潜在客户超过10亿人次。2022年，博士伦独立上市，目前市值约为70亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211091603ab6e1322&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211091603ab6e1322&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BLSP4452.SGD","BK4585","BX","BK4135","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","BK4198","IE00BLSP4239.USD","IE00BBT3K403.USD","IE00BGHQF748.EUR","BK4588","IE00BN8TJ469.HKD","IE0004445239.USD","BLCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2482411755","title":"博士伦：两款新的专业叶黄素膳食营养补充剂将上架|直击进博会","url":"https://stock-news.laohu8.com/highlight/detail?id=2482411755","media":"新浪科技","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2482411755?lang=zh_cn&edition=full","pubTime":"2024-11-09 15:39","pubTimestamp":1731137940,"startTime":"0","endTime":"0","summary":"11月9日消息，第七届中国国际进口博览会正在火热进行中，首次亮相进博会的博士伦在会上展示了专业叶黄素膳食营养补充剂以及干眼、青光眼、抗炎、宠物健康等多个领域的专业产品矩阵。其中，博士伦Artelac眼舒润滴眼液与PreserVision专业叶黄素膳食营养补充剂系列多款新品是首秀。　　博士伦内部人士表示，其中Areds2配方、辅酶Q10两款专业叶黄素膳食营养补充剂目前已经在香港仓，进博会结束后，就准备在京东首先上架。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-11-09/doc-incvnafk7685694.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BLCO","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2481746180","title":"Bausch + Lomb Corporation2024财年第三财季实现净利润4.00百万美元，同比增加104.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481746180","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2481746180?lang=zh_cn&edition=full","pubTime":"2024-11-08 00:00","pubTimestamp":1730995235,"startTime":"0","endTime":"0","summary":"11月8日，Bausch + Lomb Corporation公布财报，公告显示公司2024财年第三财季净利润为4.00百万美元，同比增加104.76%；其中营业收入为11.96亿美元，同比增加18.77%，每股基本收益为0.01美元。从资产负债表来看，Bausch + Lomb Corporation总负债68.54亿美元，其中短期债务30.00百万美元，资产负债比为1.98，流动比率为1.58。机构评级：截至2024年11月8日，当前有12家机构对Bausch + Lomb Corporation目标价做出预测，其中目标均价为21.75美元，其中最低目标价为18.00美元，最高目标价为26.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108000109abaaa0ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108000109abaaa0ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BLCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2476583411","title":"1000亿，博士伦要被卖了","url":"https://stock-news.laohu8.com/highlight/detail?id=2476583411","media":"投中网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2476583411?lang=zh_cn&edition=full","pubTime":"2024-10-18 10:55","pubTimestamp":1729220120,"startTime":"0","endTime":"0","summary":"最近，拥有171年历史，潜在客户约10亿人次的眼科巨头博士伦，被端上了“餐桌”：黑石集团和 TPG或将联手出价130亿美元至140亿美元（至多人民币1000亿元），从博士康手中将其买下。      ....","market":"us","thumbnail":"https://inews.gtimg.com/om_ls/OXy2iVGFsi0i1TX1hetqV0GNRbVks4wsPujWymsi1-vPEAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OXy2iVGFsi0i1TX1hetqV0GNRbVks4wsPujWymsi1-vPEAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241018A02YSS00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241018A02YSS00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["BLCO","BK4198"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bausch.com","stockEarnings":[{"period":"1week","weight":-0.0104},{"period":"1month","weight":-0.0006},{"period":"3month","weight":0.0356},{"period":"6month","weight":0.0394},{"period":"1year","weight":0.1457},{"period":"ytd","weight":0.0035}],"compareEarnings":[{"period":"1week","weight":-0.0119},{"period":"1month","weight":-0.0067},{"period":"3month","weight":0.0247},{"period":"6month","weight":0.1652},{"period":"1year","weight":0.1515},{"period":"ytd","weight":0.1207}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Bausch + Lomb Corporation于2020年8月19日在加拿大注册成立。他们是一家全球领先的眼保健公司，致力于保护和增强全球数百万人的视力——从出生的那一刻到生命的每个阶段。他们全面整合了超过400种产品的产品组合，旨在为他们的客户提供其一生中全方位的眼部健康需求。他们的标志性品牌建立在他们近170年历史中建立的客户的深厚信任和忠诚之上。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.0322},{"month":2,"riseRate":0.75,"avgChangeRate":0.051832},{"month":3,"riseRate":0.25,"avgChangeRate":-0.044533},{"month":4,"riseRate":0.25,"avgChangeRate":-0.089856},{"month":5,"riseRate":0.5,"avgChangeRate":0.013606},{"month":6,"riseRate":0.6,"avgChangeRate":0.031728},{"month":7,"riseRate":0.6,"avgChangeRate":0.0378},{"month":8,"riseRate":0.6,"avgChangeRate":-0.000477},{"month":9,"riseRate":0.6,"avgChangeRate":0.032191},{"month":10,"riseRate":0.25,"avgChangeRate":-0.018874},{"month":11,"riseRate":0.5,"avgChangeRate":0.019192},{"month":12,"riseRate":0.75,"avgChangeRate":0.024591}],"exchange":"NYSE","name":"博士伦","nameEN":"Bausch + Lomb Corp."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"博士伦(BLCO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供博士伦(BLCO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"博士伦,BLCO,博士伦股票,博士伦股票老虎,博士伦股票老虎国际,博士伦行情,博士伦股票行情,博士伦股价,博士伦股市,博士伦股票价格,博士伦股票交易,博士伦股票购买,博士伦股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"博士伦(BLCO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供博士伦(BLCO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}